Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut

Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

More In Business

Cheddar Morning News Briefings of March 9th

Cheddar Morning News Briefings

Morning Alexa Flash Briefings of March 9th

Morning Alexa Flash Briefings

Today Explained: The Pay Gap

Today Explained dives into a new report that explains how much the economy would improve if we can close the gender pay gap.

U.S. Judge: California Can't Ban Alligator Imports, Sales

California cannot ban the importation and sale of crocodile and alligator products, a federal judge has ruled, in a victory for the state of Louisiana, which challenged the ban along with businesses in multiple states.

What to Know About Student Loan Repayments

Jake Falcon, the founder of Falcon Wealth Advisors, joined Cheddar News to give some tips about student loan repayments.

Spotify Rolls Out Major App Redesign

Spotify Rolls Out Major App Redesign

Two Eyedrop Brands Recalled for Contamination

Two Eyedrop Brands Recalled for Contamination

U.S. Agency Opens Probe Into 120,000 Tesla Model Y Vehicles

U.S. Agency Opens Probe Into 120,000 Tesla Model Y Vehicles

Musk: Next Generation of Tesla to Be Smaller & Mostly Autonomous

Musk: Next Generation of Tesla to Be Smaller & Mostly Autonomous

Berenberg Downgrades Tesla, There's 'Less Room For Disappointment'

Berenberg Downgrades Tesla, There's 'Less Room For Disappointment'

Load More